rs754816201
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000890.5(KCNJ5):c.1186G>A(p.Ala396Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,612,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000890.5 missense
Scores
Clinical Significance
Conservation
Publications
- familial hyperaldosteronism type IIIInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- Andersen-Tawil syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- long QT syndrome 13Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- long QT syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNJ5 | NM_000890.5 | c.1186G>A | p.Ala396Thr | missense_variant | Exon 3 of 3 | ENST00000529694.6 | NP_000881.3 | |
KCNJ5 | NM_001354169.2 | c.1186G>A | p.Ala396Thr | missense_variant | Exon 4 of 4 | NP_001341098.1 | ||
KCNJ5 | XM_011542810.4 | c.1186G>A | p.Ala396Thr | missense_variant | Exon 3 of 3 | XP_011541112.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNJ5 | ENST00000529694.6 | c.1186G>A | p.Ala396Thr | missense_variant | Exon 3 of 3 | 1 | NM_000890.5 | ENSP00000433295.1 | ||
KCNJ5 | ENST00000338350.4 | c.1186G>A | p.Ala396Thr | missense_variant | Exon 4 of 4 | 1 | ENSP00000339960.4 | |||
KCNJ5 | ENST00000533599.1 | c.1186G>A | p.Ala396Thr | missense_variant | Exon 2 of 2 | 1 | ENSP00000434266.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152176Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000202 AC: 5AN: 247726 AF XY: 0.00000744 show subpopulations
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1460822Hom.: 0 Cov.: 33 AF XY: 0.0000289 AC XY: 21AN XY: 726762 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74324 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: KCNJ5 c.1186G>A (p.Ala396Thr) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 247726 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.1186G>A in individuals affected with Hyperaldosteronism, Familial, Type III and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 520527). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Long QT syndrome 13;C3838758:Familial hyperaldosteronism type III Uncertain:1
- -
Long QT syndrome Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.A396T variant (also known as c.1186G>A), located in coding exon 2 of the KCNJ5 gene, results from a G to A substitution at nucleotide position 1186. The alanine at codon 396 is replaced by threonine, an amino acid with similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. According to data from gnomAD, the frequency for this variant is above the maximum credible frequency for an endocrine disease-causing variant in this gene based on internally established thresholds (Karczewski et al. Nature. 2020 May;581(7809):434-443; Whiffin et al. Genet Med. 2017 10;19:1151-1158). Based on the supporting evidence, the association of this alteration with KCNJ5-related long QT syndrome is unknown; however, the association of this alteration with KCNJ5-related hyperaldosteronism is unlikely. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at